307 related articles for article (PubMed ID: 29751014)
41. Genome editing via delivery of Cas9 ribonucleoprotein.
DeWitt MA; Corn JE; Carroll D
Methods; 2017 May; 121-122():9-15. PubMed ID: 28410976
[TBL] [Abstract][Full Text] [Related]
42. CRISPR/Cas9-mediated 2-sgRNA cleavage facilitates pseudorabies virus editing.
Tang YD; Guo JC; Wang TY; Zhao K; Liu JT; Gao JC; Tian ZJ; An TQ; Cai XH
FASEB J; 2018 Aug; 32(8):4293-4301. PubMed ID: 29509513
[TBL] [Abstract][Full Text] [Related]
43. CRISPR-Cas9-Mediated Genome Editing and Transcriptional Control in Yarrowia lipolytica.
Schwartz C; Wheeldon I
Methods Mol Biol; 2018; 1772():327-345. PubMed ID: 29754237
[TBL] [Abstract][Full Text] [Related]
44. Efficient multiplex genome editing by CRISPR/Cas9 in common wheat.
Li J; Zhang S; Zhang R; Gao J; Qi Y; Song G; Li W; Li Y; Li G
Plant Biotechnol J; 2021 Mar; 19(3):427-429. PubMed ID: 33150679
[No Abstract] [Full Text] [Related]
45. An Agrobacterium-Mediated CRISPR/Cas9 Platform for Genome Editing in Maize.
Lee K; Zhu H; Yang B; Wang K
Methods Mol Biol; 2019; 1917():121-143. PubMed ID: 30610633
[TBL] [Abstract][Full Text] [Related]
46. Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9.
Gundry MC; Brunetti L; Lin A; Mayle AE; Kitano A; Wagner D; Hsu JI; Hoegenauer KA; Rooney CM; Goodell MA; Nakada D
Cell Rep; 2016 Oct; 17(5):1453-1461. PubMed ID: 27783956
[TBL] [Abstract][Full Text] [Related]
47. Paving the way towards precise and safe CRISPR genome editing.
Sledzinski P; Dabrowska M; Nowaczyk M; Olejniczak M
Biotechnol Adv; 2021; 49():107737. PubMed ID: 33785374
[TBL] [Abstract][Full Text] [Related]
48. Generating Mutant for a Stress-Responsive Gene in Rice Using CRISPR-Cas9 System.
Prakash CS; Sunkar R
Methods Mol Biol; 2024; 2832():281-290. PubMed ID: 38869803
[TBL] [Abstract][Full Text] [Related]
49. CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations.
Cullot G; Boutin J; Toutain J; Prat F; Pennamen P; Rooryck C; Teichmann M; Rousseau E; Lamrissi-Garcia I; Guyonnet-Duperat V; Bibeyran A; Lalanne M; Prouzet-Mauléon V; Turcq B; Ged C; Blouin JM; Richard E; Dabernat S; Moreau-Gaudry F; Bedel A
Nat Commun; 2019 Mar; 10(1):1136. PubMed ID: 30850590
[TBL] [Abstract][Full Text] [Related]
50. Ultra-deep sequencing validates safety of CRISPR/Cas9 genome editing in human hematopoietic stem and progenitor cells.
Cromer MK; Barsan VV; Jaeger E; Wang M; Hampton JP; Chen F; Kennedy D; Xiao J; Khrebtukova I; Granat A; Truong T; Porteus MH
Nat Commun; 2022 Aug; 13(1):4724. PubMed ID: 35953477
[TBL] [Abstract][Full Text] [Related]
51. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
Vermersch E; Jouve C; Hulot JS
Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
[TBL] [Abstract][Full Text] [Related]
52. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
[TBL] [Abstract][Full Text] [Related]
53. Gene Disruption Using CRISPR-Cas9 Technology.
Hu N; Malek SN
Methods Mol Biol; 2019; 1881():201-209. PubMed ID: 30350208
[TBL] [Abstract][Full Text] [Related]
54. Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms.
Farboud B; Jarvis E; Roth TL; Shin J; Corn JE; Marson A; Meyer BJ; Patel NH; Hochstrasser ML
J Vis Exp; 2018 May; (135):. PubMed ID: 29889198
[TBL] [Abstract][Full Text] [Related]
55. Analysis of NHEJ-Based DNA Repair after CRISPR-Mediated DNA Cleavage.
Song B; Yang S; Hwang GH; Yu J; Bae S
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203807
[TBL] [Abstract][Full Text] [Related]
56. An introduction and use of the CRISPR-Cas systems.
Singh V
Prog Mol Biol Transl Sci; 2021; 179():1-10. PubMed ID: 33785173
[TBL] [Abstract][Full Text] [Related]
57. Gene Editing With TALEN and CRISPR/Cas in Rice.
Bi H; Yang B
Prog Mol Biol Transl Sci; 2017; 149():81-98. PubMed ID: 28712502
[TBL] [Abstract][Full Text] [Related]
58. Battling CRISPR-Cas9 off-target genome editing.
Li D; Zhou H; Zeng X
Cell Biol Toxicol; 2019 Oct; 35(5):403-406. PubMed ID: 31313008
[No Abstract] [Full Text] [Related]
59. Era of Genomic Medicine: A Narrative Review on CRISPR Technology as a Potential Therapeutic Tool for Human Diseases.
Kotagama OW; Jayasinghe CD; Abeysinghe T
Biomed Res Int; 2019; 2019():1369682. PubMed ID: 31687377
[TBL] [Abstract][Full Text] [Related]
60. Efficient Editing of the Nuclear
Guzmán-Zapata D; Sandoval-Vargas JM; Macedo-Osorio KS; Salgado-Manjarrez E; Castrejón-Flores JL; Oliver-Salvador MDC; Durán-Figueroa NV; Nogué F; Badillo-Corona JA
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
